[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK37591D0 - Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse - Google Patents

Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse

Info

Publication number
DK37591D0
DK37591D0 DK91375A DK37591A DK37591D0 DK 37591 D0 DK37591 D0 DK 37591D0 DK 91375 A DK91375 A DK 91375A DK 37591 A DK37591 A DK 37591A DK 37591 D0 DK37591 D0 DK 37591D0
Authority
DK
Denmark
Prior art keywords
protein
preparing
procedure
expression vector
baculovirus expression
Prior art date
Application number
DK91375A
Other languages
Danish (da)
English (en)
Other versions
DK37591A (da
Inventor
Richard W Compans
Ranjit Ray
Original Assignee
Molecular Eng Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Eng Ass filed Critical Molecular Eng Ass
Publication of DK37591A publication Critical patent/DK37591A/da
Publication of DK37591D0 publication Critical patent/DK37591D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK91375A 1988-09-02 1991-03-01 Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse DK37591D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24087788A 1988-09-02 1988-09-02
PCT/US1989/003740 WO1990002566A1 (fr) 1988-09-02 1989-08-29 Proteine de fusion de paramyxovirus, procede de production utilisant un vecteur d'expression de baculovirus de recombinaison, vaccin comprenant ladite proteine et son utilisation

Publications (2)

Publication Number Publication Date
DK37591A DK37591A (da) 1991-03-01
DK37591D0 true DK37591D0 (da) 1991-03-01

Family

ID=22908302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91375A DK37591D0 (da) 1988-09-02 1991-03-01 Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse

Country Status (8)

Country Link
EP (1) EP0433371A4 (fr)
JP (1) JPH04501058A (fr)
AU (1) AU4314489A (fr)
DK (1) DK37591D0 (fr)
IL (1) IL91500A0 (fr)
NZ (1) NZ230425A (fr)
WO (1) WO1990002566A1 (fr)
ZA (1) ZA896715B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611784B2 (en) * 1988-04-22 1991-06-20 Pharmacia & Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
JP2649285B2 (ja) * 1990-11-29 1997-09-03 藤倉化成株式会社 ヒトパラインフルエンザ４ａ型ウイルスフュージョンプロテイン遺伝子及び該遺伝子を含む物質
WO1993001833A1 (fr) * 1991-07-17 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Vaccin ameliore
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
DE4407489A1 (de) * 1994-03-07 1995-09-14 Bayer Ag Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines
US5641751A (en) * 1995-05-01 1997-06-24 Centocor, Inc. Tumor necrosis factor inhibitors
NZ548255A (en) 2004-02-02 2010-10-29 Ambrx Inc Modified human interferon polypeptides and their uses
CN102532321B (zh) 2004-06-18 2018-10-12 Ambrx公司 新颖抗原结合多肽和其用途
SG161210A1 (en) 2004-12-22 2010-05-27 Ambrx Inc Methods for expression and purification of recombinant human growth hormone
EP2284191A3 (fr) 2004-12-22 2011-07-20 Ambrx, Inc. Procédé de préparation de hGH
ZA200704927B (en) 2004-12-22 2009-09-30 Ambrx Inc Compositions of aminoacyl-tRNA synthetase and uses thereof
EP1833993A4 (fr) 2004-12-22 2009-07-22 Ambrx Inc Formulations d'hormone de croissance humaine comportant un acide aminé codé de manière non naturelle
CN104803865A (zh) 2004-12-22 2015-07-29 Ambrx公司 含有非天然氨基酸和多肽的组合物、涉及非天然氨基酸和多肽的方法以及其用途
JP2008541769A (ja) 2005-06-03 2008-11-27 アンブレツクス・インコーポレイテツド 改善されたヒトインターフェロン分子及びそれらの使用
US20090018029A1 (en) 2005-11-16 2009-01-15 Ambrx, Inc. Methods and Compositions Comprising Non-Natural Amino Acids
JP5399906B2 (ja) 2006-09-08 2014-01-29 アンブルックス，インコーポレイテッド 脊椎動物細胞用のハイブリッドサプレッサーｔｒｎａ
DK2615108T3 (en) 2006-09-08 2017-01-30 Ambrx Inc Modified human plasma polypeptide or fc scaffolds and their applications
PT2064333E (pt) 2006-09-08 2014-06-09 Ambrx Inc Supressor híbrido arnt para células de vertebrados
BRPI0809583B1 (pt) 2007-03-30 2022-02-22 Ambrx, Inc Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
JP5547083B2 (ja) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
EP2247743B1 (fr) 2008-02-08 2016-04-06 Ambrx, Inc. Polypeptides leptine modifiés et leurs utilisations
NZ591235A (en) 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
JP5709754B2 (ja) 2008-09-26 2015-04-30 アンブルックス, インコーポレイテッドAmbrx, Inc. 非天然アミノ酸による複製に依存する微生物およびワクチン
CN102232085A (zh) 2008-09-26 2011-11-02 Ambrx公司 修饰的动物促红细胞生成素多肽和其用途
EA201290541A1 (ru) 2009-12-21 2013-05-30 Амбркс, Инк. Модифицированные бычьи соматотропиновые полипептиды и их применение
AU2010341518B2 (en) 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
NZ607069A (en) 2010-08-17 2014-10-31 Ambrx Inc Modified relaxin polypeptides and their uses
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
PT3412302T (pt) 2014-10-24 2021-06-09 Bristol Myers Squibb Co Polipéptidos de fgf-21 modificados e utilizações dos mesmos
EP3580232B1 (fr) 2017-02-08 2023-09-20 Bristol-Myers Squibb Company Polypeptides de relaxine modifiés comprenant un activateur pharmacocinétique et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847081A (en) * 1984-07-18 1989-07-11 W. R. Grace & Co.-Conn. Synthetic bovine parainfluenza viral proteins
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現

Also Published As

Publication number Publication date
WO1990002566A1 (fr) 1990-03-22
ZA896715B (en) 1990-09-26
NZ230425A (en) 1992-07-28
AU4314489A (en) 1990-04-02
EP0433371A1 (fr) 1991-06-26
DK37591A (da) 1991-03-01
EP0433371A4 (en) 1991-10-30
IL91500A0 (en) 1990-04-29
JPH04501058A (ja) 1992-02-27

Similar Documents

Publication Publication Date Title
DK37591A (da) Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse
DK82784A (da) Fremgangsmaade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
DK628488D0 (da) Stabilt mikroemulsion-rensemiddel og fremgangsmaade til fremstilling deraf samt dets anvendelse
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DK316189D0 (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
ATA257190A (de) Virales polypeptid
DK120188A (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DK162054C (da) Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme
DK19887A (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaader til deres fremstilling, midler indeholdende forbindelserne og deres anvendelse
DK364288A (da) Vulkaniseret kautsjukemne, fremgangsmaade til fremstilling af dette samt etiket til brug ved fremgangsmaaden
DK378187A (da) Bata-lactamforbindelse, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelsen samt mellemprodukter til anvendelse ved fremstillingen deraf
CA2125486A1 (fr) Epitopes p1a1 et p1a2 de la proteine plaquettaire gpiiia, leur preparation et leur utilisation
DK196687A (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
DK88989D0 (da) Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK469189D0 (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK200489D0 (da) Fremgangsmaade til fremstilling af polypeptider
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK231089D0 (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
DK614589D0 (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
DK247884A (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider, fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK440688D0 (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089D0 (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment